A Two-Part Study of BOTOX® Therapy for Ischemic Digits
NCT01309802
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
48
Enrollment
OTHER
Sponsor class
Conditions
Raynaud's Disease
Interventions
DRUG:
onabotulinum toxin type-A
Sponsor
Southern Illinois University